NUR : Pre-Sim Assignment – Junetta Cooper
Scenario Background
Situation: The patient’s, Junetta Cooper’s, husband brought her to the emergency department this
morning at 0815 because she was experiencing angina unrelieved by nitroglycerin. She has been
evaluated in the emergency room, and she is now awaiting cardiac catheterization tomorrow to evaluate
the extent of the coronary artery disease.
Background: Mrs. Cooper is a 75-year-old African American woman who has had primary
hypertension since age 55 years. Her blood pressure has been treated with antihypertensive drugs. She
has a 1-year history of stable (exertional) angina pectoris secondary to CAD. Her pain has been
successfully controlled with the nitroglycerin patch and sublingual nitroglycerin tablets.
Learning Objectives
General:
□ Identify the pharmacotherapeutics of the drug regimen
□ Evaluate the appropriateness of the medication order for the particular patient (e.g.,
contraindications, lab results, physical assessment data, allergies, potential interactions, drug
history, and medication reconciliation)
□ Calculate the medication dosages as appropriate
□ Administer medications, ensuring safety in the pharmacological process and applying rights of
medication administration
□ Evaluate the patient response to medication (e.g., therapeutic effects, side effects, and
adverse reactions)
□ Provide appropriate patient-centered patient education on medications (at the appropriate
level, including side effects, interactions, etc.)
Scenario-Specific:
□ Discuss recommended antihypertensive treatment practices and preferred medication for blood
pressure management
□ Explain mechanism of action, common side effects of nitroglycerin, and use of various
nitroglycerin formulations for angina treatment
□ Implement appropriate nursing interventions for a patient with angina
□ Provide patient education on proper storage and administration of various forms of nitroglycerin
Recommended Reading
1. Karch, A. M. (2020). Focus on Nursing Pharmacology, 8th Edition.
2. Drugs Affecting Blood Pressure, Chapter 43, pp. 428-453Antianginal
3. Agents, Chapter 46, pp. 793-807